New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
07:41 EDTBONE, NUVA, MDXG, AXGN, BAXS, SNN, RTIX, ANIK, OSIR, SMA, CNMD, GMEDCanaccord to hold a conference
Musculoskeletal Conference is being held in New Orleans, Louisiana on March 11.
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
12:50 EDTSNNSmith & Nephew, Stryker seen as potential headliners of 2015 M&A, TheDeal says
Subscribe for More Information
07:45 EDTMDXGMiMedx upside seen in new markets, says Canaccord
Subscribe for More Information
February 26, 2015
12:15 EDTNUVANuVasive management to meet with Piper Jaffray
Meetings to be held in New York on March 3 and in Denver on March 4 hosted by Piper Jaffray.
07:36 EDTMDXGMiMedx backs FY15 revenue view $175M-$190M, consensus $183.61M
Subscribe for More Information
07:36 EDTMDXGMiMedx backs Q1 revenue view $40M-$41M, consensus $40.54M
Subscribe for More Information
07:34 EDTMDXGMiMedx reports Q4 EPS 3c, consensus 3c
Subscribe for More Information
February 25, 2015
16:25 EDTANIKAnika Therapeutics reports Q4 EPS 51c, consensus 48c
Subscribe for More Information
16:22 EDTGMEDGlobus Medical enters agreement to acquire Branch Medical Group
Subscribe for More Information
16:21 EDTGMEDGlobus Medical backs FY15 EPS view about $1.01, consensus $1.02
Backs FY15 revenue view about $510M, consensus $512.92M.
16:20 EDTGMEDGlobus Medical reports Q4 adjusted EPS 30c, consensus 25c
Subscribe for More Information
February 24, 2015
16:30 EDTNUVANuVasive announces updated Non-GAAP definition
NuVasive announced that it will implement an updated non-GAAP definition in Q1. NuVasive will redefine its non-GAAP cost of goods sold, gross margin, operating expenses, operating margin and earnings per share financial measures from its existing non-GAAP definition to include the impact of non-cash stock-based compensation and certain intellectual property related litigation expenses, both of which had previously been excluded in the company's calculation of these non-GAAP financial measures. In addition to GAAP results, these non-GAAP measures are intended to provide additional information to enable investors to assess the Company's operations in the same way management assesses operations. Management uses non-GAAP measures to budget, evaluate and measure the company's performance and sees these results as an indicator of the company's ongoing business performance. The company believes these changes in non-GAAP reporting increase transparency and better reflect the underlying financial performance of the business. CFO Quentin Blackford said, "This update allows us to provide investors with a meaningful non-GAAP measurement that represents the performance of our core business on a more inclusive, comprehensive basis. Importantly, this change does not impact NuVasive's plan to deliver at least 100 basis points of operating margin expansion each year, as well as improved EBITDA margins for the next several years as we rapidly scale the business in the U.S. and internationally and capture well-identified opportunities to drive profitability."
16:18 EDTNUVANuVasive sees FY15 adjusted EPS approximately $1.10, consensus $1.53
Sees FY15 revenue approximately $810M, consensus $811.03M, which includes an approximate $10M of currency headwinds.
16:16 EDTNUVANuVasive reports Q4 adjusted EPS 39c, consensus 37c
Reports Q4 revenue $204.3M, consensus $201.39M.
February 20, 2015
10:01 EDTMDXGOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:17 EDTMDXGMiMedx upgraded to Strong Buy with $13 target at Needham
Needham upgraded MiMedx to Strong Buy from Buy saying it has renewed confidence the company can exceed consensus 2015 estimates after meeting with management. The firm has a $13 price target for shares.
07:09 EDTRTIXBTIG to hold a conference
Subscribe for More Information
06:45 EDTMDXGMiMedx upgraded to Strong Buy from Buy at Needham
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use